In vitro dual effect of arsenic trioxide on hemopoiesis: Inhibition of erythropoiesis and stimulation of megakaryocytic maturation

This publication has 50 references indexed in Scilit:

• Arsenic Trioxide: New Clinical Experience With an Old Medication in Hematologic Malignancies
  Journal of Clinical Oncology, 2005
• All-trans retinoic acid/As ₂ O ₃ combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
  Proceedings of the National Academy of Sciences, 2004
• United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
  Journal of Clinical Oncology, 2001
• Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
  Blood, 2000
• Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL
  Blood, 2000
• Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients
  Blood, 1999
• Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
  New England Journal of Medicine, 1998
• Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells
  JNCI Journal of the National Cancer Institute, 1998
• Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
  Proceedings of the National Academy of Sciences, 1997
• In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins
  Blood, 1996